| HIV (N = 2,548) | TB (N = 197,562) | HIV & TB (N = 137) | |||
---|---|---|---|---|---|---|
Sex, male : female | 2,355(92.4%):193(7.6%) | 124,183(62.9%):73,379(37.1%) | 132(96.4%):5(3.6%) | |||
Age, median (range) | 37.0 (4-80) | 44 (0-97) | 39.5 (19.9-79.1) | |||
0-9 | 2 (0.1%) | 1,000 (0.5%) | 0 (0%) | |||
10-19 | 60 (2.4%) | 12,575 (6.4%) | 1 (0.7%) | |||
20-29 | 576 (22.6%) | 39.638 (20.1%) | 19 (13.9%) | |||
30-39 | 873 (34.3%) | 32,231 (16.3%) | 51 (37.2%) | |||
40-49 | 583 (22.9%) | 30,515 (15.4%) | 41 (29.9%) | |||
50-59 | 318 (12.5%) | 23,206 (11.7%) | 14 (10.2%) | |||
60- | 136 (5.3%) | 58,397 (29.6%) | 11 (8.0%) | |||
Year | Cases | Incidence (cases/105) | Cases | Incidence (cases/105) | Cases | Incidence (cases/105) |
2001 | 327 | 0.69 | 42,737 | 90.3 | 17 | 0.036 |
2002 | 398 | 0.84 | 38,801 | 81.4 | 20 | 0.042 |
2003 | 534 | 1.11 | 36,227 | 75.6 | 21 | 0.044 |
2004 | 610 | 1.27 | 36,041 | 74.8 | 40 | 0.083 |
2005 | 680 | 1.41 | 43,781 | 90.7 | 39 | 0.081 |
CD4 count at diagnosis, median(IQR) (/mm3) | 315.0 (186.0-464.0) | Â | Â | 301.0 (171.5-460.0) | ||
TB type (% among patients with TB) | Â | Â | Â | Â | Â | Â |
   Pulmonary |  |  | 183,640 (92.0%) |  | 111 (81.0%) |  |
Smear positive | Â | Â | 72,599 (36.4%) | Â | 42 (30.7%) | Â |
   Extrapulmonary |  |  | 16,021 (8.0%) |  | 26 (19.0%) |  |
Pleurisy | Â | Â | 6,852 (3.4%) | Â | 3 (2.2%) | Â |
Lymphnode | Â | Â | 3,675 (1.8%) | Â | 10 (7.3%) | Â |
Gastrointestinal | Â | Â | 1,797 (0.9%) | Â | 5 (3.6%) | Â |
Nervous | Â | Â | 657 (0.3%) | Â | 3 (2.2%) | Â |
Skin | Â | Â | 272 (0.1%) | Â | 1 (0.7%) | Â |
Other organs | Â | Â | 2,169 (1.1%) | Â | 1 (0.7%) | Â |
Disseminated | Â | Â | 599 (0.3%) | Â | 3 (2.2%) | Â |